complaint open to increasingly a.lert patients for which, or for whom, the onus of management in the code of practice is being placed on the nurse in charge of the ward and her record book.
I estimate that there are already 11 or 12 channels of complaint open to the customers. By all means let us establish machinery that allows free conument and honest answer, but let it be a system that will be effective in practice and one that does not unnecessarily overburden the ward staff.-I am, etc., C. GRIMSHAW Henley-on-Thames t Report of the Committee on Hospital Complaints Procedure. London, H.M.S.O., 1973. Diagnosis of Rubella SIR,-Your recent leading article on this subject (16 February, p. 257) lists in considerable detail the clinical features of importance and states that the diagnosis of rubella can sometimes be made with ease, especially during epidemics. Though many would agree with this statement, we would like to stress that because rubella often presents atypically, or because infection which on clinical grounds closely resembles rubella may be caused by other viruses, tragedies still result from an over-confident clinical diagnosis in which undue emphasis Is placed on the clinical features.
If during pregnancy a diagnosis of rubella is considered at all possible, however remotely, we feel that virological investigations must be carried out. Assessment is based on clinical data, including details of date, type, and duration of contact, as well as on serological studies employing haemagglutination inhibition and complement fixation tests and, if necessary, tests to detect rubella-specific IgM.1 2 Though your article states only that "arthralgia has been a feature in some e.pidemics of rubella," we feel that it is one of the few reliable clinical features in postpubertal females, since we have detected it in approximately 70% of nurses at St.
Thomas's Hospital during both epidemic and non-epidemic times. The knees, fingers, and wrists are the most frequently affected joints.
In addition, undue reliance cannot always be placed on the detection of rubellaspecific IgM in a single serum sample. In our experience employing serum fractionation by sucrose density gradients, sera collected during the first week of illness may not always contain detectable virus-specific IgM despite the presence of adequate levels of haemagglutination-inhibiting antibodies. However, it will generally be present in a sample collected a few days later. Though rubella-specific IgM may be considered to be indicative of a recently acquired infection, failure to detect specific IgM in late convalescent sera may be due to quantitative factors. Thus if techniques of increased sensitivity are used (details of which will be published later) rubella-specific IgM can be detected for up to 14 months after both uncomplicated naturaly acquired and vaccine-induced infections. Furthermore, when naturally immune ,persons are challenged they may develop not only serum IgG and IgA booster responses but also small amounts of transient rubella-specific IgM.
We were also impressed by Dr. Catherine Peckham's findings (16 February, p. 259) which showed that the administration of pooled human immunoglobulin may induce a subclinical infection which may not result in fetal damage. Might it now be worth conducting trials in which inmmunoglobulin obtained from recently convalescent patients with high antibody titres is given to those seronegative women who have been closely exposed to rubella, provided it can be ad- Rubella in Pregnancy SIR,-Dr. Catherine S. Peckham (16 February, p. 259) has confirmed that subclinical maternal rubella is far less likely to lead to congenital defects in offspring than clinical rubella.
From her previous work and in contrast to the Public Health Laboratory Service report' she also feels that specific immunoglobulin had and may still have a role in preventing clinical rubella during pregnancy. Accepting that imnmunoglobulin can mitigate rubella given clearly defined conditions, it is still very doubtful whether it could be really effective under the widely varying circumstances of everyday practice. On the other hand, Dr. Peckham reported that the defects in six children whose mothers had clinical rubella and immunoglobulin in the first trimester of pregnancy were mainly perceptive deafness. Possibly sone specific antibody from the immunoglobulin reached the fetal circulation and had a limiting effect on viral multiplication in the fetal tissues, thereby preventing the more immediately apparent and severe cardiac or eye defects.
It should be clearly understood therefore that immnunoglobulin should be offered only to women who understand and are prepared to accept the risk of having a baby with a congenital abnormality. with various cytotoxic dreugs in recipients of renal allografts.23 Under the conditions of the tesit the number of rosette-forming cells is less than 50 per 1,000 nucleated cells,3 and the exact identity of the central cells in the rosettes has until recently been a matter of debate.4 5 It is now, however, generally accepted that these central cells are thymusdependent (T) lymphocytes.6-9 E-rosette (Erythrocyte-rosette) formation occurs in a proportion of human lymphocytes (65% in control subjects) with sheep red blood cells at low temperatures, and is now an accepted characteristic of humnan T-lymphocytes.6-8
We have employed a test that makes use of the inhibition of E-rosettes by antithymocyte globulin (A.T.G.) in increasing concentrations. We have shown this to be a sensitive and highly reproducible test in the investigation of cell-mediated inmunity in thyroid and related disorders.10 The methods for E-and EAC-rosette (Erythrocyte-Antibody-Complement-rosette) formation and the rosette inhibition test have been described eleswhere.8-'0
The data shown in the figure are based on experiments employing mouse serum as a source of complement for EAC-rosette formation."1 The response curves of EACrosettes to A.T.G. were identical when mouse complement was replaced by human or guinea-pig complement, though different proportions of lymphocytes formed EACrosettes. The mean "inhibition concentration"-that is, that concentration of A.T.G. ng/ml ATG. 10,000
,uq/ml bMP causing 25% inhibitiosette formation-was 482±+31 (S.D.) ng/nil in nor;mal controls. Honever, when concentrations of A.T.G. up to 6,000 ng/n0 were employed there was no significant reduction in EACrosettes. When 6-mercaptopurine (6 MP) was used (rather than A.T.G.) to inhibit E-rosette forantion the mean inhibition concentration was 62 ± 10-8 Mg/ml. The inhibition concentrations in Graves's and Hashimoto's diseases, reported elsewhere, were markedly elevated.'0
The tesit appears to have the advantage of directly measuring a T-lymphocyte function. Though the nature of the metabolic alterations produced by A.T.G. on T-lymphocytes to inhibit rosette formation is not dlear, the end point of that effect indicates the "setting" (possibly the "degree" of sensitization) of a specific lymphocyte.10 Evidence favouring this assumption is provided by consistent increases in the amount of A.L.S. necessary to cause E-rosette inhibition during graft rejection following organ transplantation,2312 as well as other experimental evidence.13
Contrary to the inhibitory effect on Erosette formation, A.T.G. in varying concentrations failed to cause significant inhibition of EAC-rosettes-that is, B-lymphocytes. It
